Contact Us
Find A Doctor

Retisert Treatment of Diabetic Macular Edema Study

Principal Investigator:

Ronald Gentile, M.D.

Enrollment Status:



To evaluate Retisert™ in the management of patients with diabetic macular edema.


The two year trial results demonstrated that 30% of eyes receiving standard of care (repeat laser treatment) had a worsening of their Diabetic Retinopathy compared with only 10% of eyes receiving a Retisert™ implant. This was statistically significant. Retisert™ also reduced retinal thickening involving the fovea (the centre most part of the macula responsible for sharp, central vision) and led to a statistically significant three line improvement in vision.

For more information:


Contact Us

Dr. Ronald Gentile, Principal Investigator

Alex Yang, Research CoordinatorTel: (212) 979-4024

Address310 E. 14th StreetNew York, NY 10003

View all locations